Literature DB >> 15534815

A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs.

Shen Luo1, Kurt Michler, Paul Johnston, Peter W Macfarlane.   

Abstract

The corrected QT interval (QTc) is widely used in pharmaceutical studies and clinical practice. Bazett's QT correction formula is still the most popular, despite Simonson's warning in 1961 that it could not be recommended. Other QTc formulae, e.g. Fridericia, Framingham, and Hodges, are also used. This study compares these four formulae using 10,303 normal ECGs recorded from four US hospitals. QT intervals were measured by the same computer program on ECGs confirmed by physicians. The distributions of QTc based on Fridericia, Framingham, and Hodges formulae were similar but Bazett's was significantly wider. The global group QTc-heart rate (HR) correlation coefficients were calculated as Bazett 0.33, Fridericia 0.24, Framingham 0.26, and Hodges 0.11, with the uncorrected QT-HR correlation being 0.82. Overall by far, Hodges QTc is significantly less correlated with HR compared to the others. Certain subgroup correlations of gender and low, mid, or high HR show that one individual formula can out-perform the others, whereby automated selection of QT correction formula based on the patient's HR and gender could be implemented as another option in products. The upper normal limits of corrected QTc were determined by excluding the top 2% from the global distribution charts as follows: Bazett 483 ms, Fridericia 460 ms, Framingham 457 ms, and Hodges 457 ms. Whether for males and/or females, the middle range of HR from 60 to 99 bpm has similar upper normal limits of QTc for all formulae except Bazett. Numerous references recommend 420 to 440 ms as the threshold for reporting prolonged QTc when using Bazett's formula. Based on this database, 30% of apparently normal ECGs would be reported as having abnormal QT intervals for the 440 ms threshold, or 10% if 460 ms is chosen, compared to <2% for the other formulae. It was also noted that QT has a linear trend with HR but not with RR.

Entities:  

Mesh:

Year:  2004        PMID: 15534815     DOI: 10.1016/j.jelectrocard.2004.08.030

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  125 in total

Review 1.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  QTc prolongation associated with atypical antipsychotic use in the treatment of adolescent-onset anorexia nervosa.

Authors:  Blair Ritchie; Mark L Norris
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-02

Review 3.  Recording sympathetic nerve activity from the skin.

Authors:  Thomas H Everett; Anisiia Doytchinova; Yong-Mei Cha; Peng-Sheng Chen
Journal:  Trends Cardiovasc Med       Date:  2017-05-10       Impact factor: 6.677

4.  Modulators of normal electrocardiographic intervals identified in a large electronic medical record.

Authors:  Andrea H Ramirez; Jonathan S Schildcrout; Dana L Blakemore; Dan R Masys; Jill M Pulley; Melissa A Basford; Dan M Roden; Joshua C Denny
Journal:  Heart Rhythm       Date:  2010-10-29       Impact factor: 6.343

5.  In Vivo Surface Electrocardiography for Adult Zebrafish.

Authors:  Yali Zhao; Morgan Yun; Sean A Nguyen; Michelle Tran; Thao P Nguyen
Journal:  J Vis Exp       Date:  2019-08-01       Impact factor: 1.355

6.  Comparison of formulas for calculation of the corrected QT interval in infants and young children.

Authors:  Derek Q Phan; Michael J Silka; Yueh-Tze Lan; Ruey-Kang R Chang
Journal:  J Pediatr       Date:  2015-01-31       Impact factor: 4.406

7.  Tpeak-to-Tend interval corrected for heart rate: A more precise measure of increased sudden death risk?

Authors:  Kelvin C M Chua; Carmen Rusinaru; Kyndaron Reinier; Audrey Uy-Evanado; Harpriya Chugh; Karen Gunson; Jonathan Jui; Sumeet S Chugh
Journal:  Heart Rhythm       Date:  2016-08-11       Impact factor: 6.343

8.  An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.

Authors:  Joachim Wernicke; Alberto Lledó; Joel Raskin; Daniel K Kajdasz; Fujun Wang
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

9.  Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials.

Authors:  Mitesh J Borad; Arundhati D Soman; Martin Benjamin; Daniel Casa; Waibhav D Tembe; Barbara F Piper; Ramesh Ramanathan; Raoul Tibes; Gayle Jameson; Karen Ansaldo; Daniel D Von Hoff
Journal:  Invest New Drugs       Date:  2012-12-16       Impact factor: 3.850

10.  A new experimentally validated formula to calculate the QT interval in the presence of left bundle branch block holds true in the clinical setting.

Authors:  Harilaos Bogossian; Gerrit Frommeyer; Ilias Ninios; Eleni Pechlivanidou; Fuad Hasan; Quy Suu Nguyen; Dejan Mijic; Axel Kloppe; Zana Karosiene; Artak Margkarian; Dirk Bandorski; Dominik Schultes; Damir Erkapic; Melchior Seyfarth; Bernd Lemke; Lars Eckardt; Markus Zarse
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-08-26       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.